Nicholas Murgolo
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Receptor Mechanisms and Signaling, Monoclonal and Polyclonal Antibodies Research, Malaria Research and Control, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption(2004)1,760 cited
- → Antibiotic Susceptibility Profiles of Escherichia coli Strains Lacking Multidrug Efflux Pump Genes(2001)498 cited
- → Selective small-molecule inhibition of an RNA structural element(2015)415 cited
- → Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation(2006)269 cited
- → SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development(2021)214 cited
- → PCSK9 binds to multiple receptors and can be functionally inhibited by an EGF-A peptide(2008)180 cited
- → Identification and Characterization of a Novel RF-amide Peptide Ligand for Orphan G-protein-coupled Receptor SP9155